for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Bioera SpA

BIE.MI

Latest Trade

0.67EUR

Change

0.00(0.00%)

Volume

2,524

Today's Range

0.67

 - 

0.67

52 Week Range

0.53

 - 

1.35

As of on the Italian SE (Mercato Continuo Italia) ∙ Minimum 15 minute delay

Pricing

Previous Close
0.67
Open
0.67
Volume
2,524
3M AVG Volume
0.73
Today's High
0.67
Today's Low
0.67
52 Week High
1.35
52 Week Low
0.53
Shares Out (MIL)
5.69
Market Cap (MIL)
3.80
Forward P/E
--
Dividend (Yield %)
--

Next Event

Bioera SpA Annual Shareholders Meeting

Latest Developments

More

Bioera: Unit Meditalia Holding To Sell 33% Stake In Meditalia To IGEA Pharma

Bioera: Idea Team Does Not Exercise Option Right To Buy 51.3% Ki Group Holding

Bioera H1 Net Loss Widens To EUR 4.2 Mln

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Bioera SpA

Bioera SpA is an Italy-based company engaged in the production and distribution of organic products, natural cosmetics and traditional food products. The company’s activities are divided into two sectors. The Biological and Natural products sector, through its subsidiaries and affiliated entities, is active in the distribution of natural and organic products; production of organic food from vegetables; manufacture of oil from organic agriculture, and distribution of traditional food products, as well as in the sector of natural origin cosmetics. The Holding sector provides activities of the Company as a parent of the group. The Company controls entities, such as Organic Oils Italia Srl, La Fonte della Vita Srl, KI Group SpA and Organic Food Retail Srl.

Contact Info

Via Pompeo Litta 9

+39.02.36695124

http://www.bioera.it/

Executive Leadership

Daniela Garnero Santanche

Chairman of the Board

Canio Giovanni Mazzaro

Chief Executive Officer, General Manager, Director

Davide Mantegazza

Vice Chairman, Independent Director

Davide Guerra

Head of Administration and Control, Financial Reporting Officer

Silvia Garnero

Director

Key Stats

Price To Earnings (TTM)
--
Price To Sales (TTM)
0.10
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
-65.96
Return on Equity (TTM)
-22.99

Latest News

Latest News

BRIEF-Bioera Signs Settlemnet Agreement With Idea Team

* SAID ON SATURADY CO SIGNED SETTLEMENT AGREEMENT WITH KI GROUP , BIOFOOD ITALIA, AND IDEA TEAM

BRIEF-Bioera: Unit Meditalia Holding To Sell 33% Stake In Meditalia To IGEA Pharma

* UNIT MEDITALIA HOLDING S.R.L SIGNS DEAL TO SELL 33% STAKE IN MEDITALIA SRL TO IGEA PHARMA

BRIEF-Bioera: Idea Team Does Not Exercise Option Right To Buy 51.3% Ki Group Holding

* SAID ON MONDAY THAT IDEA TEAM HAD NOT EXERCISED OPTION RIGHT TO BUY 51.3% OF KI GROUP HOLDING FROM BIOERA AND BIOFOOD

BRIEF-Bioera H1 Net Loss Widens To EUR 4.2 Mln

* SAID ON THURSDAY H1 REVENUE EUR 18.4 MLN VS EUR 21.9 MLN YEAR AGO

BRIEF-Bioera FY Net Loss Shrinks To EUR 3.6 Mln

* REPORTED ON MONDAY FY REVENUE EUR 41.4 MLN VS EUR 47.1 MLN YEAR AGO

BRIEF-Bioera Receives From Request From Bracknor Investment For Conversion Of 7 Bonds

* SAID ON MONDAY THAT RECEIVED FROM BRACKNOR INVESTMENT REQUEST FOR CONVERSION OF 7 BONDS

BRIEF-Bioera: Court Rejects Liability Action Against Directors In Office Until May 2010

* SAID ON MONDAY THAT IT HAD BEEN NOTIFIED OF THE DECISION OF THE COURT IN MILAN TO REJECT ITS LIABILITY ACTION AGAINST THE DIRECTORS WHO WERE IN OFFICE UNTIL MAY 4, 2010

BRIEF-Bioera: Bracknor Investment Subscribes To Fourth Tranche Of Convertible Bond

* SAID ON MONDAY THAT BRACKNOR INVESTMENT HAS SUBSCRIBED FOURTH TRANCHE OF THE CONVERTIBLE BOND

BRIEF-Bioera FY Net Loss Widens To EUR 5.1 Mln

* FY REVENUE EUR 47.1 MILLION VERSUS EUR 54.4 MILLION YEAR AGO

BRIEF-Bioera: Regional Tax Commission Upholds Appeal Against Fine On FY 2005

* SAID ON MONDAY THAT THE REGIONAL TAX COMMISSION IN EMILIA ROMAGNA UPHELD THE COMPANY'S APPEAL REGARDING A CHECK ON THE 2005 FISCAL YEAR

BRIEF-Bioera: Bracknor subscribes to second tranche of convertible bond​

* BRACKNOR INVESTMENT HAS SUBSCRIBED THE SECOND TRANCHE OF THE CONVERTIBLE BOND

BRIEF-Bioera receives conversion request for 8 convertible bonds from Bracknor Investment

* SAID ON FRIDAY IT RECEIVED FROM BRACKNOR INVESTMENT CONVERSION NOTICE OF 8 BONDS AS PART OF THE FIRST TRANCHE OF CONVERTIBLE BONDS ISSUED ON SEPT. 12, BASED ON AGREEMENT SIGNED BETWEEN BIOERA AND BRACKNOR ON AUG. 1

BRIEF-Bioera H1 net loss widens to EUR ‍2.1​ mln

* H1 NET LOSS EUR 2.1 MILLION VERSUS LOSS EUR 0.6 MILLION YEAR AGO

BRIEF-Bioera: Bracknor subscribes to first tranche of convertible bond​

* BRACKNOR INVESTMENT HAS SUBSCRIBED TO FIRST TRANCHE OF CONVERTIBLE BOND

BRIEF-Bioera signs investment agreement with Bracknor to issue 3 mln euro bond

* SIGNS INVESTMENT AGREEMENT WITH BRACKNOR INVESTMENT FOR THE ISSUE OF A CONVERTIBLE BOND FOR TOTAL 3 MILLION EUROS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Bioera approves issue of non-convertible bond loan "Bioera S.p.A.- Euro 5,000,000 Bond Loan 2017-2022"

* HAS APPROVED THE ISSUE OF A NON-CONVERTIBLE BOND LOAN "BIOERA S.P.A. - EURO 5,000,000 BOND LOAN 2017-2022 "OF A TOTAL NOMINAL AMOUNT OF UP TO EURO 5,000,000 AND AT A RATE OF 7% GROSS ANNUAL

BRIEF-Bioera unit invests 550,000 euros in Meditalia

* Says board approves the investment in Meditalia Srl through Bioera Start Up Italia

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up